A chance of cure for every patient with chronic myeloid leukemia?

被引：12

作者：

Hehlmann, R ^{[1
]}

机构：

[1] Univ Mannheim, Med Klin 3, D-68305 Mannheim, Germany

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1998年 / 338卷 / 14期

关键词：

D O I：

10.1056/NEJM199804023381409

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：980 / 982

页数：3

共 14 条

[1]

Carella AM, 1997, HAEMATOLOGICA, V82, P478

[2]

Delannoy A, 1997, J NATL CANCER I, V89, P1616

[3]

Gale RP, 1998, BLOOD, V91, P1810

[4]

GOLDMAN JM, 1993, BLOOD, V82, P2235

[5] Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia [J].

Guilhot, F ;

Chastang, C ;

Michallet, M ;

Guerci, A ;

Harousseau, JL ;

Maloisel, F ;

Bouabdallah, R ;

Guyotat, D ;

Cheron, N ;

Nicolini, F ;

Abgrall, JF ;

Tanzer, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (04) :223-229

[6] Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia [J].

Hansen, JA ;

Gooley, TA ;

Martin, PJ ;

Appelbaum, F ;

Chauncey, TR ;

Clift, RA ;

Petersdorf, EW ;

Radich, J ;

Sanders, JE ;

Storb, RF ;

Sullivan, KM ;

Anasetti, C .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (14) :962-968

[7] RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA [J].

HEHLMANN, R ;

HEIMPEL, H ;

HASFORD, J ;

KOLB, HJ ;

PRALLE, H ;

HOSSFELD, DK ;

QUEISSER, W ;

LOFFLER, H ;

HOCHHAUS, A ;

HEINZE, B ;

GEORGII, A ;

BARTRAM, CR ;

GRIESSHAMMER, M ;

BERGMANN, L ;

ESSERS, U ;

FALGE, C ;

QUEISSER, U ;

MEYER, P ;

SCHMITZ, N ;

EIMERMACHER, H ;

WALTHER, F ;

FETT, W ;

KLEEBERG, UR ;

KABISCH, A ;

NERL, C ;

ZIMMERMANN, R ;

MEURET, G ;

TICHELLI, A ;

KANZ, L ;

TIGGES, FJ ;

SCHMID, L ;

BROCKHAUS, W ;

TOBLER, A ;

REITER, A ;

PERKER, M ;

EMMERICH, B ;

VERPOORT, K ;

ZANKOVICH, R ;

VONWUSSOW, P ;

PRUMMER, O ;

THIELE, J ;

BUHR, T ;

CARBONELL, F ;

ANSARI, H .

BLOOD, 1994, 84 (12) :4064-4077

[8] Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction [J].

Hochhaus, A ;

Lin, F ;

Reiter, A ;

Skladny, H ;

Mason, PJ ;

vanRhee, F ;

Shepherd, PCA ;

Allan, NC ;

Hehlmann, R ;

Goldman, JM ;

Cross, NCP .

BLOOD, 1996, 87 (04) :1549-1555

[9] Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia [J].

Laporte, JP ;

Gorin, NC ;

Rubinstein, P ;

Lesage, S ;

Portnoi, MF ;

Barbu, V ;

Lopez, M ;

Douay, L ;

Najman, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (03) :167-170

[10] Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: A decision analysis [J].

Lee, SJ ;

Kuntz, KM ;

Horowitz, MM ;

McGlave, PB ;

Goldman, JM ;

Sobocinski, KA ;

Hegland, J ;

Kollman, C ;

Parsons, SK ;

Weinstein, MC ;

Weeks, JC ;

Antin, JH .

ANNALS OF INTERNAL MEDICINE, 1997, 127 (12) :1080-1088

← 1 2 →